Laboratory Test-Based Biomarker in MASH: Proprietary Test to Assess Liver Fibrosis
Executive summary of Enhanced Liver Fibrosis (ELF) staging cutoffs, FDA prognostic authorization, and clinical confounders.
If your clinic doesn't have a FibroScan machine on site — or if body habitus makes ultrasound readings tricky — the ELF test lets your doctor check liver scarring from a single blood draw. Scores below 7.7 point toward minimal or no scarring, 9.8 or higher signals likely advanced fibrosis (F3+), and 11.3 or higher raises strong concern for cirrhosis and future liver complications.
| Test | Cutoffs | Strengths | Limitations |
|---|---|---|---|
| ELF™a |
F0/1: <7.71,2 ≥F2: ≥7.7 to <9.81,2 ≥F3: ≥9.81,2 F4: ≥11.31,2 |
|
|